NCT01352962 2026-04-14
Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
Clinical Trials
9 trialsNCT04257448 2025-09-30
SEPION
GWT-TUD GmbH
Phase 1/2 Completed
NCT07184424 2025-09-19
Lenalidomide
Beijing Tsinghua Chang Gung Hospital
Phase NA Completed
NCT01547260 2022-08-22
LENAGEM
Karolinska University Hospital
Phase 1/2 Completed
NCT01254617 2020-03-13
ADCC
National Cancer Institute (NCI)
Phase 1 Completed
NCT00717756 2020-02-17
Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial
Brown University
Phase 2 Completed
NCT01545804 2017-02-09
Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma
National Taiwan University Hospital
Phase 2 Completed
NCT01183663 2016-06-03
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00837031 2013-03-13
Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas
SCRI Development Innovations, LLC
Phase 2 Completed